Skip to content
About
Overview
Who We Are
Leadership Team
Advisors
Investors
News
Technology
Intro to ACE2
Our Technology
Pipeline
COVID 19
Kidney Disease
Acute Kidney Injury
Chronic Kidney Disease
Contact
Home
/
About
/
News
News
Nick Batlle
2023-05-10T16:52:51+00:00
News
Bioengineered Protein May Prevent COVID Infections and Improve Survival
Northwestern Medicine
Study Shows Cell Membrane-Bound Enzyme is Essential for COVID-19 Infection
Northwestern Medicine
Angiotensin Therapeutics Inc. announces publication of a study using a soluble ACE2 protein designed for COVID-19
Press Release
A Novel Soluble ACE2 Protein Provides Lung and Kidney Protection in Mice Susceptible to Lethal SARS-CoV-2 Infection
Journal of the American Society of Nephrology
Can you spot the fake receptor? The coronavirus can’t either.
MIT Technology Review
Podcast:
Kidneys, COVID-19 and ACE2 Connection with Daniel Batlle, MD
Northwestern University
Fooling coronavirus with new decoy protein renders it impotent
Northwestern University
Novel protein construct prevents lethal COVID-19 in mice
News Medical
Angiotensin Therapeutics Inc. Announces Publication of a Novel Approach to COVID 19 Therapy.
Press Release.
Angiotensin Therapeutics Inc. Announces Publication of a Novel Approach to COVID 19 Therapy.
BioSpace.
New Protein Neutralizes COVID in Tiny Human Kidney.
Northwestern University.